Clinical Trial Results: Positive data from Advaxis' clinical trials often leads to increased investor confidence and higher stock prices. Conversely, negative or inconclusive results can cause the price to fall.

Regulatory Approvals: FDA approvals for Advaxis' immunotherapy drugs are major catalysts that typically drive significant stock price increases. Rejections or delays can negatively impact the stock.

Partnerships and Collaborations: Strategic partnerships with larger pharmaceutical companies or research institutions can boost investor sentiment and increase the stock price due to validation and potential funding.

Financial Performance: Advaxis' cash position, burn rate, and ability to secure funding influence investor confidence. Concerns about financial stability can depress the stock price.

Market Sentiment: Overall market conditions and investor appetite for risk, particularly in the biotech sector, can affect ADXS.US. Positive market sentiment tends to lift the stock.

Competition: The competitive landscape in the immunotherapy space impacts investor perception of Advaxis' potential. Strong competition can pressure the stock price.

News and Media Coverage: News articles, analyst ratings, and social media discussions can influence investor behavior and affect the stock price.